SMTL ID : 9kgn.1

Discovery of an orally bioavailable reversible covalent SARS-CoV-2 Mpro inhibitor with pan-coronavirus activity

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.89 Å

Oligo State

homo-dimer

Ligands

2 x ACE- VAL- LEU- ELL: compound 3(Non-covalent)

ACE-VAL-LEU-ELL.1: 17 residues within 4Å: Chain B: H.46, M.54, F.145, L.146, N.147, G.148, S.149, C.150, H.168, H.169, M.170, E.171, H.177, D.192, R.193, Q.194, T.195 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:H.46, B:M.54 Hydrogen bonds: B:G.148, B:S.149, B:S.149, B:C.150, B:H.169, B:E.171, B:E.171, B:E.171, B:E.171, B:Q.194, B:T.195 Water bridges: B:Q.194 ACE-VAL-LEU-ELL.2: 16 residues within 4Å: Chain A: H.46, F.145, L.146, N.147, G.148, S.149, C.150, H.168, H.169, M.170, E.171, H.177, D.192, R.193, Q.194, T.195 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:H.46, A:M.170 Hydrogen bonds: A:G.148, A:C.150, A:H.169, A:E.171, A:E.171, A:E.171, A:Q.194

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tan, Q.W. et al., Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 M pro Inhibitor with Pan-Coronavirus Activity. J.Med.Chem. (2025)

Release Date

2025-08-20

Peptides

3C-like proteinase nsp5: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
A

3C-like proteinase nsp5

Related Entries With Identical Sequence